knowledge -WSS

knowledge

author：leisure time 2025-10-02 22:24:02 - browse：52855

Adobe

Akili Interactive, which in 2020 made waves by receiving Food and Drug Administration clearance for its video game that improves symptoms of ADHD in children, on Wednesday announced it would reorient its business around selling its products directly to users over the counter, rather than by prescription.

In connection with the move away from prescription sales, Akili will reduce its workforce by 40%, which the company projects will extend its runway into the second half of 2025. The Boston-based company will continue offering its pediatric treatment, EndeavorRx, by prescription until it can convert it to over-the-counter labeling — it plans to submit data to FDA in 2024.

Akili went public last year and though its prescription sales were slowly increasing, the company’s costs far outstripped its revenues. In its second-quarter results reported in August, Akili said it earned just $114,000 on $15.3 million in expenses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： FDA investigates CAR

leisure time

WSS

With clinical trial data readouts, here's how to spot spin

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

The UK government moves asylum

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

BIO selects John Crowley as new CEO

UnitedHealth’s Optum accused of antitrust violations in California

hotspot

knowledge

knowledge

Cancer drug shortages should be causing more outrage

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

Peter Hotez and the public health issue of online harassment

Takeda, Janssen join wearable maker to measure scratching

Sports medicine is finally prioritizing gender equality

Trump Jan. 6 attorney John Lauro is ex

Novavax promises a turnaround & Lilly roils the obesity market

Cigna, Humana reportedly in talks to merge

hotspot

Trump Jan. 6 attorney John Lauro is ex

J&J to emphasize cancer drugs, stop much of its vaccine research

Flagship Pioneering launches a new biotech in two countries

Mayo Clinic plans $5B tech

Illinois to ban advertising for guns allegedly marketed to kids and militants

Appeals court upholds Josh Duggar's conviction for downloading child sex abuse images

focus

leisure time

leisure time

knowledge